Global Levothyroxine Sodium Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Levothyroxine Sodium Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Levothyroxine Sodium is the sodium salt of levothyroxine, a synthetic levoisomer of thyroxine (T4) that is similar to the endogenous hormone produced by the thyroid gland.
Levothyroxine Sodium report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Levothyroxine Sodium market is projected to reach US$ 4382.9 million in 2034, increasing from US$ 3604.2 million in 2022, with the CAGR of 2.8% during the period of 2024 to 2034. Demand from Hospitals and Pharmacy are the major drivers for the industry.
Abbvie was the global greatest company in Levothyroxine Sodium industry, with the revenue market Share of 23% , followed by Mylan Pharma, Merck, Pfizer, Lannett Company, Novartis, Fresenius Kabi, IBSA, Piramal Critical Care, Abbott.North America is the largest Levothyroxine Sodium market with about 69% market share. Europe is follower, accounting for about 17% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Levothyroxine Sodium market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Abbvie
Mylan Pharma
Merck
Pfizer
Lannett Company
Novartis
Fresenius Kabi
IBSA
Piramal Critical Care
Abbott
Segment by Type
Oral
Injection
Hospitals
Pharmacy
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Levothyroxine Sodium market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Levothyroxine Sodium, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Levothyroxine Sodium industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Levothyroxine Sodium in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Levothyroxine Sodium introduction, etc. Levothyroxine Sodium Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Levothyroxine Sodium market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Levothyroxine Sodium report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Levothyroxine Sodium market is projected to reach US$ 4382.9 million in 2034, increasing from US$ 3604.2 million in 2022, with the CAGR of 2.8% during the period of 2024 to 2034. Demand from Hospitals and Pharmacy are the major drivers for the industry.
Abbvie was the global greatest company in Levothyroxine Sodium industry, with the revenue market Share of 23% , followed by Mylan Pharma, Merck, Pfizer, Lannett Company, Novartis, Fresenius Kabi, IBSA, Piramal Critical Care, Abbott.North America is the largest Levothyroxine Sodium market with about 69% market share. Europe is follower, accounting for about 17% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Levothyroxine Sodium market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Abbvie
Mylan Pharma
Merck
Pfizer
Lannett Company
Novartis
Fresenius Kabi
IBSA
Piramal Critical Care
Abbott
Segment by Type
Oral
Injection
Segment by Application
Hospitals
Pharmacy
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Levothyroxine Sodium market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Levothyroxine Sodium, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Levothyroxine Sodium industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Levothyroxine Sodium in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Levothyroxine Sodium introduction, etc. Levothyroxine Sodium Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Levothyroxine Sodium market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.